Ambu A/S (OTCMKTS:AMBBY) Short Interest Down 50.0% in December

Ambu A/S (OTCMKTS:AMBBYGet Free Report) was the target of a significant drop in short interest in December. As of December 15th, there was short interest totalling 100 shares, a drop of 50.0% from the November 30th total of 200 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is currently 0.3 days.

Ambu A/S Stock Performance

OTCMKTS:AMBBY remained flat at $13.02 during mid-day trading on Friday. 16 shares of the company’s stock traded hands, compared to its average volume of 678. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.09. The stock has a market capitalization of $3.06 billion and a P/E ratio of 108.50. The business has a 50-day simple moving average of $16.20 and a 200 day simple moving average of $18.48. Ambu A/S has a 52-week low of $13.02 and a 52-week high of $22.65.

Ambu A/S Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, December 23rd. Stockholders of record on Friday, December 6th were paid a dividend of $0.0557 per share. The ex-dividend date was Friday, December 6th. Ambu A/S’s dividend payout ratio (DPR) is 16.67%.

About Ambu A/S

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Read More

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.